Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine versus bupivacaine in bilateral maxillary nerve block for cleft lip and palate surgery
PACTR202308910451816Recruiting
- Sponsor
- Faculty of Medicine of Sousse
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Trial of ropivacaine and bupivacaine in cleft lip (CL) and cleft palate (2 arms), sponsored by Faculty of Medicine of Sousse. Primary endpoint: Postoperative pain. Started Jul 2023; status: recruiting.
02
Drugs
ropivacainebupivacaine
03
Conditions
cleft lip (CL)cleft palate
Beyond the preview
Go deeper on PACTR202308910451816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202308910451816.